Press release
What Is The Leading Driver Behind Rising Surgical Procedures Driving Growth Due To Enhanced Healthcare Access And Advancements Market Expansion in 2025
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Will the Post-Operative Nausea And Vomiting Industry Market Size Be by 2025?
Significant expansion has been observed in the post-operative nausea and vomiting market over the recent past, projecting an escalation from its 2024 valuation of $2.11 billion to $2.25 billion by 2025, registering a compound annual growth rate of 6.8%. This robust historical trajectory is fueled by factors such as escalating research and development efforts, augmented need for sophisticated treatment modalities, increases in overall healare spending, a heightened concentration on individualized patient care, and the broader uptake of digital health innovations.
What's the Long-Term Growth Forecast for the Post-Operative Nausea And Vomiting Market Size Through 2029?
Anticipation surrounds the post-operative nausea and vomiting market, projecting notable expansion over the coming years, set to reach a valuation of $2.94 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 6.9%; this upward trajectory is fueled by several key factors such as escalating pharmaceutical needs, the increasing application of combination therapies, heightened general awareness, greater healare expenditures, an aging global demographic, and an increasing incidence of cancer diagnoses, while prevailing market dynamics are characterized by the emergence of sophisticated antiemetic treatments, strategic partnerships, novel medication designs, the incorporation of cutting-edge diagnostic instruments, and the deployment of electronic simulation apparatus.
View the full report here:
https://www.thebusinessresearchcompany.com/report/post-operative-nausea-and-vomiting-global-market-report
What Are the Key Growth Drivers Fueling the Post-Operative Nausea And Vomiting Market Expansion?
An increase in the volume of surgical operations is anticipated to fuel the expansion of the market dedicated to managing post-operative nausea and vomiting (PONV). Surgical interventions involve medical techniques where instruments are employed to inspect, address, or excise compromised tissues, organs, or irregularities through incision or manipulation. This upward trend in surgeries is attributed to innovations in medical science, rendering operations safer, more efficacious, and less invasive, which, in turn, boosts patient willingness and broadens their accessibility. Effective PONV care significantly benefits the surgical process itself by boosting patient well-being, shortening recuperation durations, lessening the potential for adverse events, facilitating better subsequent care, and ultimately yielding superior results from the operation. Demonstratively, data from the Australian Institute of Health and Welfare, a government body in Australia, indicated that for the 2023-24 fiscal year, a total of 771,600 individuals entered hospitals for surgery sourced from public elective waiting lists, marking a 4.9% year-over-year growth from 2022-23, a fact reported in November 2024; consequently, the growing frequency of surgeries directly contributes to the market growth for PONV treatments.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22109&type=smp
What Are the Key Trends Driving Post-Operative Nausea And Vomiting Market Growth?
Key players within the sphere of post-operative nausea and vomiting treatments are directing their efforts toward pioneering injectable pharmaceuticals, employing sophisticated emulsion bases and mechanisms for continuous drug delivery to boost therapeutic success and extend the duration of symptomatic relief experienced by individuals recovering from surgery. Essential injectable medicines signify vital substances delivered parenterally, engineered for prompt and potent intervention in severe or time-sensitive health circumstances. To illustrate, in July of 2024, Avenacy, a specialized drug manufacturer situated in the United States, introduced its Palonosetron Hydrochloride Injection, packaged in 0.25 mg/5 mL vials intended for single administration, aiming to assist medical professionals in minimizing medication mistakes and enhancing patient well-being. This particular injectable is approved for prophylactic use against emesis triggered by chemotherapy, alongside being prescribed for the control of nausea and vomiting subsequent to operations for a full day post-procedure, thereby establishing a dependable therapeutic choice for those vulnerable to these adverse effects.
How Is the Post-Operative Nausea And Vomiting Market Segmented?
The post-operative nausea and vomitingmarket covered in this report is segmented -
1) By Treatment Type: Serotonin Antagonists; Steroids; Dopamine Antagonists; Neurokinin NK-1 Receptor Antagonists; Non-pharmacological Treatment; Other Treatment Types
2) By Route Of Administration: Oral; Intravenous; Transdermal; Other Route Of Administrations
3) By Patient Demographics: Pediatric Patients; Adult Patients; Geriatric Patients
4) By Surgical Procedure Type: Orthopedic Surgery; Gynecological Surgery; General Surgery; Cardiac Surgery; Ophthalmic Surgery
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Serotonin Antagonists Type: Ondansetron; Granisetron; Palonosetron; Dolasetron; Tropisetron
2) By Steroids Type: Dexamethasone; Methylprednisolone; Hydrocortisone; Prednisolone; Betamethasone
3) By Dopamine Antagonists Type: Metoclopramide; Droperidol; Prochlorperazine; Domperidone; Chlorpromazine
4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant; Fosaprepitant; Rolapitant; Netupitant; Casopitant
5) By Non-Pharmacological Treatment Type: Acupressure; Aromatherapy; Hypnotherapy; Electroacupuncture; Ginger Supplements
6) By Other Treatment Types: Antihistamines; Anticholinergics; s; Combination Therapy; Herbal & Natural Remedies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=22109&type=smp
Which Companies Are Leading the Charge in Post-Operative Nausea And Vomiting Market Innovation?
Major companies operating in the post-operative nausea and vomiting market are Pfizer Inc., Merck KGaA, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited. , Baxter Corporation, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Inc., Fresenius Kabi AG, Eisai Co. Ltd., Dr. Reddy's Laboratories, Kyowa Hakko Kirin Taiwan Co. Ltd., Cipla Ltd., Alkem Laboratories Ltd., Eagle Pharmaceuticals Inc. , Camurus AB, Helsinn Healare SA, Heron Therapeutics Inc., Advacare Pharma
Which Regions Are Leading the Global Post-Operative Nausea And Vomiting Market in Revenue?
North America was the largest region in the post-operative nausea and vomiting market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-operative nausea and vomiting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22109
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Is The Leading Driver Behind Rising Surgical Procedures Driving Growth Due To Enhanced Healthcare Access And Advancements Market Expansion in 2025 here
News-ID: 4281705 • Views: …
More Releases from The Business Research Company
Gas Pipeline Infrastructure Market to Surpass $3336.1 Billion by 2029 | Key Tren …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Gas Pipeline Infrastructure Market Grow by 2025 in Terms of Size and Growth?
Over the past few years, the gas pipeline infrastructure market has seen consistent expansion. The market is projected to increase from $2756.98 billion in 2024 to $2839.09 billion in 2025, with a compound annual growth rate…
Soaring Demand Set to Propel Abetalipoproteinemia Management Market to $0.67 Bil …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Abetalipoproteinemia Management Market Through 2025?
The overall valuation of the abetalipoproteinemia management sector has experienced a robust expansion recently; projecting forward, this market is anticipated to expand from its 2024 figure of $0.44 billion to reach $0.48 billion by 2025, demonstrating a…
Welding Gas/Shielding Gas Market Size to Reach $4.71 Billion by 2029 | Growth at …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Welding Gas/Shielding Gas Industry?
In the past years, significant growth has been observed in the welding gas/shielding gas market size. The market is projected to expand from $3.17 billion in 2024 to $3.38 billion in 2025, exhibiting a compound annual growth rate (CAGR)…
Perforating Gun Global Market Insights: Growth Drivers, Size & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Perforating Gun Industry?
The market size of perforating guns has seen a consistent growth in recent times. It is projected to expand from $1.14 billion in 2024 to $1.18 billion in 2025, showcasing a compound annual growth rate (CAGR) of 3.0%. The…
More Releases for Nausea
Sick of Simulator/VR/Gaming Nausea?
Nix VR-induced nausea with Sea-Band® Nausea Relief Bands
In the US, it's estimated that over 64 million children between the ages of 2 and 17 play video games. This represents approximately 91% of children in that age range . So if you know a teen or a tween, there's a good chance you know a passionate gamer.
What you might not know is that VR-induced motion sickness, or simulator sickness, can be…
Nausea And Vomiting Treatment Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Nausea And Vomiting Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Nausea And Vomiting Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million…
Nausea And Vomiting Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Nausea And Vomiting Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Nausea And Vomiting Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nausea And Vomiting…
Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea an …
The report “Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market: Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook. Inquire for a discount on this CINV & PONV Market report at http://www.marketreportsonline.com/contacts/discount.php?name=745672.
The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe along with…
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Oncology) pipeline landscape.
Chemotherapy induced nausea and vomiting or CINV is nausea and…
Chemotherapy-induced Nausea and Vomiting Drugs Market 2017
Market Research Analysts forecast the global CINV drugs market to grow at a CAGR of 5.41% during the period 2017-2021.
According to the report, the high unmet medical need in the market has driven the R&D activities of existing as well as new vendors. Helsinn is one of the leading companies that has a strong pipeline of CINV drugs with two drug candidates in Phase III and Phase I stages. Helsinn…
